Last updated on February 2018

Feasibility Study of Adjuvant Treatment With S-1 in Patients After R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric Junction


Brief description of study

Multicenter trial in Germany:

Feasibility Study of Adjuvant Treatment with S-1 in Patients after R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric Junction with the aim to show the feasibility and tolerability of two different adjuvant S-1 treatment regimens in Caucasian patients and to determine the recommended dose for both treatment regimens.

Detailed Study Description

Patients will be enrolled in two cohorts.

The cohorts 1 an d2 will be conducted consecutively, started with cohort 1. Cohort 1 consists of 30 patients who receive S-1 twice daily for 18 cycles (D1-14 q 3 wks). Cohort 2 consists of 30 patients who receive S-1 twice daily for 9 cycles (D1-28, q 6 wks). Both cohorts will start with 2x 30 mg/m^2 BSA. Two dose reductions will be allowed per protocol.

Clinical Study Identifier: NCT02564367

Contact Investigators or Research Sites near you

Start Over

Christoph Schulz, Dr.

Klinikum der Universit t M nchen, Campus Gro hadern
München, Germany
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.